Where do T cell subsets stand in SARS-CoV-2 infection: an update
An outbreak of coronavirus disease 2019 (COVID-19) emerged in China in December 2019
and spread so rapidly all around the globe. It's continued and spreading more dangerously …
and spread so rapidly all around the globe. It's continued and spreading more dangerously …
T cell response in patients with COVID-19
L Liu, L Xu, C Lin - Blood Science, 2020 - mednexus.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the third zoonotic
coronavirus to have an outbreak in the first two decades of the 21st century. Human-to …
coronavirus to have an outbreak in the first two decades of the 21st century. Human-to …
[HTML][HTML] T cell immunity to SARS-CoV-2
Exceptional efforts have been undertaken to shed light into the biology of adaptive immune
responses to SARS-CoV-2. T cells occupy a central role in adaptive immunity to mediate …
responses to SARS-CoV-2. T cells occupy a central role in adaptive immunity to mediate …
Sharing CD4+ T cell loss: when COVID-19 and HIV collide on immune system
COVID-19 is a distinctive infection characterized by elevated inter-human transmission and
presenting from absence of symptoms to severe cytokine storm that can lead to dismal …
presenting from absence of symptoms to severe cytokine storm that can lead to dismal …
Updated insights into the T cell-mediated immune response against SARS-CoV-2: a step towards efficient and reliable vaccines
M Dhawan, AA Rabaan, MMA Fawarah, SA Almuthree… - Vaccines, 2023 - mdpi.com
The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune
response elicited through presently available vaccination makes it essential to recognize the …
response elicited through presently available vaccination makes it essential to recognize the …
COVID-19: The emerging immunopathological determinants for recovery or death
Hyperactivation of the host immune system during infection by SARS-CoV-2 is the leading
cause of death in COVID-19 patients. It is also evident that patients who develop …
cause of death in COVID-19 patients. It is also evident that patients who develop …
Deciphering the T cell response in SARS-CoV-2 infection
L Maggi, A Mazzoni, S De Biasi - Frontiers in Immunology, 2024 - frontiersin.org
COVID-19 is an infectious disease emerged in 2020, caused by the novel coronavirus SARS-
CoV-2. The immune system has a primary role in pathogen elimination and a rapid and …
CoV-2. The immune system has a primary role in pathogen elimination and a rapid and …
T‐cell responses and therapies against SARS‐CoV‐2 infection
Abstract Coronavirus disease 2019 (COVID‐19) is caused by SARS‐CoV‐2, a novel
coronavirus strain. Some studies suggest that COVID‐19 could be an immune‐related …
coronavirus strain. Some studies suggest that COVID‐19 could be an immune‐related …
[HTML][HTML] Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19
The contribution of CD4+ T cells to protective or pathogenic immune responses to SARS-
CoV-2 infection remains unknown. Here, we present single-cell transcriptomic analysis of> …
CoV-2 infection remains unknown. Here, we present single-cell transcriptomic analysis of> …
Cellular immune response to COVID-19 and potential immune modulators
X Zhou, Q Ye - Frontiers in Immunology, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Droplets and contacts serve as …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Droplets and contacts serve as …